Akademik Veri Yönetim Sistemi
Turk Hijyen ve Deneysel Biyoloji Dergisi, cilt.80, sa.4, ss.455-462, 2023 (Scopus, TRDizin)
Objective: The aim of the study was to determine the perspective of patients undergoing dialysis to influenza and pneumococcal vaccines and to determine the vaccination rates. Methods: 128 patients who were on dialysis program and accepted to participate in the study were included in the questionnaire study. Education levels, their knowledge about vaccinations, the reasons of those who did not want to be vaccinated, whether vaccines were recommended by their doctors, their perspective on the disease, and whether they had hospitalizations due to pneumonia or influenza were questioned. Hitit University licensed IBM SPSS 23.0 package program was used for data analysis. Nominal data were given as numbers and percentages, and chi-square test or Fisherexact test was used to compare them. A P value less than 0.05 was considered statistically significant. Results: The median age of the patients was 54 (39-67) years, and the age distribution was between 20-90 years. 51 (39.8%) of the patients were female, 77 (60.2%) were male. 58 of 128 patients were vaccinated with influenza and 16 pneumococus. Although there was a doctor’s recommendation for 80 people for influenza vaccine, 25 people had regular influenza vaccines every year. It was only 14 people who paid attention to which year they had the vaccine. 92 of the patients had a previous flu infection and seven patients had received inpatient treatment. It was observed that most patients did not care about the disease and avoided the vaccine because they thought it would heal easily. For the pneumococcal vaccine, it was observed that pneumococcal vaccine was recommended to only 37 patients and 14 people had pneumococcal vaccine once and two people had pneumococcal vaccine twice. 13 of the patients had pneumonia, but were able to survive the disease without hospitalization. Conclusion: Influenza and pneumococcal vaccinations in patients with chronic renal failure; below the target level. More studies are needed to raise vaccination rates in patients.